BDNF Augmentation Using Riluzole Reverses Doxorubicin-Induced Decline in Cognitive Function and Neurogenesis
In conclusion, this data provides pre-clinical evidence for a translationally feasible approach to enhance the neuroprotective effects of RZ treatment to prevent CRCI.
Source: Neurotherapeutics - Category: Neurology Source Type: research
More News: ALS | Anxiety | Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Learning | Neurology | Study | Universities & Medical Training